Image for illustrative purposes only. Not a real photo.

Cyclopharm secures Technegas approval at NIH

Escrito por Liezl GambePublicado Feb 18, 2026, 6:28 AMÚltima atualização Jul 6, 2026, 10:45 AM

Cyclopharm (ASX:CYC) announced the approval of its flagship technology, Technegas, for clinical use at the National Institutes of Health.

Mais formas de descobrir